TelyRx to Host Third Quarter 2026 Financial Results Conference Call on Friday, November 6, 2026 at 8:30 am ET
TelyRx Holdings (TELYF) will host its third-quarter 2026 financial results conference call and webcast on November 6, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
TelyRx Holdings (TELYF) will host its third-quarter 2026 financial results conference call and webcast on November 6, 2026. The call starts at 8:30 a.m. Eastern Time. The company expects to release results for the period ended September 30, 2026, after market close on November 5, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Clearwater, Florida--(Newsfile Corp. - October 22, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a vertically integrated, technology-enabled healthcare and pharmacy services company, today announced it will host a conference call and webcast to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). The Company expects to report its third quarter 2026 financial results for the period ended September 30, 2026, via news release after market close on Thursday, November 5, 2026.
Telephone Dial-In Access Information
The Company will host a conference call to discuss its third quarter 2026 financial results on Friday, November 6, 2026, at 8:30 a.m. Eastern Time (ET). To dial direct and enter the call through an operator, dial 1-833-752-3490 or 1-647-260-0811. The live webcast can be accessed by copying and pasting this link into a browser: https://www.gowebcasting.com/15175. Please connect approximately 15 minutes prior to the beginning of the webcast or call to ensure participation.
About TelyRx Holdings Inc.
TelyRx is an integrated digital healthcare platform that makes everyday prescription medications easier to access. Patients connect with independent, state-licensed healthcare providers who evaluate their needs and prescribe treatment when appropriate. Prescriptions are filled by TelyRx's licensed pharmacies and delivered directly to patients' doors. Serving patients across 48 U.S. states and all territories, TelyRx provides access to more than 500 common, FDA-approved medications for over 60 common health conditions through a seamless, convenient experience.
For additional information, visit www.telyrx.com or contact:
Neil Weber
Investor Relations
(647) 222-0574
investors@telyrx.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/320240